Jacobs Levy Equity Management’s Alphatec Holdings ATEC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29M Buy
+3,352,133
New +$30.5M 0.1% 176
2016
Q2
Sell
-24,108
Closed -$69K 1151
2016
Q1
$69K Sell
24,108
-9,307
-28% -$31.1K ﹤0.01% 1054
2015
Q4
$120K Buy
+33,415
New +$113K ﹤0.01% 730
2015
Q3
Sell
-2,199
Closed -$36K 807
2015
Q2
$36K Sell
2,199
-5,985
-73% -$99.7K ﹤0.01% 790
2015
Q1
$142K Sell
8,184
-14,456
-64% -$241K ﹤0.01% 726
2014
Q4
$383K Buy
22,640
+15,828
+232% +$270K 0.01% 641
2014
Q3
$139K Sell
6,812
-19,659
-74% -$361K ﹤0.01% 783
2014
Q2
$518K Buy
26,471
+3,850
+17% +$64.7K 0.01% 626
2014
Q1
$407K Buy
22,621
+8,955
+66% +$197K 0.01% 709
2013
Q4
$330K Sell
13,666
-1,167
-8% -$26.9K 0.01% 795
2013
Q3
$351K Buy
14,833
+2,892
+24% +$73.3K 0.01% 761
2013
Q2
$294K Buy
+11,941
New +$277K 0.01% 829

Other funds holding ATEC

Jacobs Levy Equity Management's ATEC Position: Q2 2026 in Review

Jacobs Levy Equity Management opened a new position in Alphatec Holdings (ATEC) in Q2 2026: 3,352,133 shares worth $29M. The stake represents 0.1% of the portfolio and ranks #176 among its holdings. This is a return to the name: Jacobs Levy Equity Management previously reported a position in ATEC as recently as Q1 2016.

Jacobs Levy Equity Management first reported a position in ATEC in Q2 2013 and has held it in 12 quarters since. 267 funds tracked by Wall St. Rank hold ATEC as of Q2 2026.

  • Jacobs Levy Equity Management held 3,352,133 shares of Alphatec Holdings worth $29M as of Q2 2026.
  • Alphatec Holdings was a new Jacobs Levy Equity Management position in Q2 2026.
  • Alphatec Holdings made up 0.1% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #176 holding.
  • Jacobs Levy Equity Management first reported a position in Alphatec Holdings in Q2 2013 and has held it in 12 quarters since.
  • 267 funds tracked by Wall St. Rank held Alphatec Holdings as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.